Other Relevant Articles - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

A Novel Familial Cardiac Arrhythmia Syndrome with Widespread ST-Segment Depression
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years
Generalizing Intensive Blood Pressure Treatment to Adults With Diabetes Mellitus
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry：The EuroCTO (CASTLE) Score
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial
Invasive Coronary Physiology After Stent Implantation: Another Step Toward Precision Medicine
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO Registry
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19

Guideline

2014 Jun 24;129(25 Suppl 2):S49-73.

JOURNAL：Circulation.

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Goff DC Jr, Lloyd-Jones DM, American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

4657

Keywords: AHA Scientific Statements; biomarkers; cardiovascular disease; cholesterol; primary prevention; risk assessment; risk reduction behavior

Full Text PDF